Acetyl-CoA carboxylase (ACC) inhibitor GS-0976 leads to...

Acetyl-CoA carboxylase (ACC) inhibitor GS-0976 leads to suppression of hepatic de novo lipogenesis and significant improvements in MRI-PDFF, MRE, and markers of fibrosis after 12 weeks of therapy in patients with NASH

Lawitz, E.J., Poordad, F., Coste, A., Loo, N., Djedjos, C.S., McColgan, B., Jia, C., Xu, R., Myers, R.P., Subramanian, G.M., McHutchison, J.G., Middleton, M.S., Sirlin, C., Nyangau, E., Fitch, M., Li,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(17)30328-8
File:
PDF, 68 KB
english, 2017
Conversion to is in progress
Conversion to is failed